Red blood cell distribution width (RDW) is a measure of hemogram. Nearly one third of COPD patients have increased RDW levels and exitus rates are higher in this group. It is suggested that elevated RDW might be related with increased mortality in COPD patients.
INTRODUCTION
Red blood cell distribution width (RDW) is a measure of red blood cell size heterogeneity and it reflects the erythrocyte morphology (1) . It is a component of complete blood count and it is used in the differential diagnosis of anemia (2) . Furthermore; systemic inflammation, ineffective erythropoiesis, nutritional deficiencies, bone marrow dysfunction or increased destruction can also cause a higher RDW. Recent evidences report that acute or chronic disorders such as cardiovascular diseases (CVD), cancer, sepsis, chronic obstructive pulmonary disease (COPD), pulmonary thromboembolism (PTE), diabetes mellitus, liver and kidney failure are related with increased RDW levels (1) (2) (3) (4) .
It is also reported that higher RDW levels may reflect underlying chronic inflammation which can result in an increased mortality (3) . There is an association between increased RDW levels and high mortality risk in both general population and some diseases including cardiovascular diseases and COPD (2, 3) . COPD is a systemic disease and inflammation has an important role on development of COPD. COPD-related inflammation may also impair erythropoiesis and cause increased RDW levels, as do other chronic inflammatory processes. But, there are limited studies evaluating the relation among COPD, mortality and RDW levels (1, 3) .
COPD is treatable and preventable systemic disease characterized by persistent airflow limitation that is usually progressive and associated with an increased inflammatory response to noxious particles and gases (5) . It is fifth leading cause of death and estimated to be the third in 2030 worldwide (6). Exacerbations are an important cause of mortality and morbidity in COPD patients (7, 8) . The aim of this study is to evaluate the relationship between the RDW level and characteristics of the COPD exacerbations.
METHODS
The medical records of the hospitalized patients with COPD exacerbation in Pulmonary Diseases Clinic were evaluated retrospectively. The exacerbation of the COPD was defined as an acute event characterized by a worsening of the respiratory symptoms that was beyond normal day-to-day variations and led to a change in medication (5).
The demographic characteristics, smoking history, duration of follow-up and the numbers of exacerbations and hospitalizations, duration of the hospital stay, need of noninvasive mechanic ventilation (NIMV) or intensive care unit (ICU) were recorded. Laboratory findings including hemogram and artery blood gas analysis which were taken on first day of hospitalization were also recorded.
Exclusion criteria
Patients with other lung diseases such as tuberculosis, bronchiectasis and interstitial lung disease were excluded. Patients with iron or vitamin deficiencies (such as B12 or folate) and recent transfusions were also excluded from the study.
Laboratory analysis
Red cell distribution width was assessed by flow cytometric analyzers as the part of the routine full blood count. RDW was calculated as (standard deviation of red cell volume/mean cell volume) × 100. The normal range was between 12.2% and 17.2% in our laboratory.
Statistical analysis
Statistical analyses of the study were performed using IBM SPSS for Windows version 20.0 (SPSS, Chicago, IL, USA). Categorical variables were expressed as counts (percentage).
Numeric variables were expressed as mean and standard deviation. Comparisons of categorical variables between the groups were performed using the Chi square test. A twosided P value <0.05 was considered statistically significant.
RESULTS
There were 35 women (18.5%), 154 men (81.5%), totally 189 patients. The mean age was 67.4± 10.6 years. The mean durations of follow-up and hospitalization were respectively 2.85±2.5 years and 8.5±5.4 days. Forty one of the patients (22%) were current smoker and 115 of them (61.8%) were ex-smoker. Respiratory infections (72%) were the most common causes of the exacerbations. Demographic data, the characteristics of exacerbation and laboratory findings of the patients were shown in Table- When the patients with increased RDW level compared to normal ones; no statistically significant difference was found with respect to the gender, smoking history, smoking package of years, numbers of the exacerbation and hospitalization, duration of hospital stay and need of NIMV or ICU (Table-4 ). However, it was found that the presence of exitus was significantly higher in patients with increased RDW level (p=0.02) ( Figure-1) .
DISCUSSION
This study demonstrated that nearly one third of the hospitalized COPD patients with exacerbation had increased RDW levels. There were no statistically significant differences of gender, smoking history, smoking package of years, numbers of the exacerbation and hospitalization, duration of hospital stay and need of NIMV or ICU in patients with increased RDW level compared to normal ones. However, it was found that the presence of exitus was significantly higher in patients with increased RDW level.
The red blood cell distribution width (RDW) is a simple and cheap parameter, which is a component of hemogram. It reflects the degree of heterogeneity of erythrocyte volume. It is also known as anisocytosis. RDW is used for differential diagnosis of anemias (2) . Beside this, RDW is a recently recognized biomarker of adverse outcome in various acute and chronic conditions (9). An increased RDW is related with both impaired erythropoiesis and abnormal red blood cell survival, which may be attributed to a variety of underlying metabolic abnormalities such as oxidative stress, inflammation, erythrocyte fragmentation and alteration of erythropoietin function (2).
Anisocytosis can also seen in some disorders such as cardiovascular disease, cancer, sepsis, diabetes, liver/kidney failure and respiratory diseases including community acquired pneumonia (CAP), venous thromboembolism and COPD (2,4,10-12). Studies evaluating the relation between COPD and RDW levels are limited (1, 3) . In a retrospective analysis of stable COPD patients, it is revealed that RDW is positively correlated with C-reactive protein (CRP), right ventricular dysfunction and pulmonary arterial hypertension (3). In a multivariable logistic regression analysis, the presence of high RDW is found to be only independent parameter predicting RV failure in COPD patients and it is suggested that RDW may be used to identify COPD patients with RV failure (13).
COPD is treatable and preventable systemic disease characterized by persistent airflow limitation that is usually progressive (5) . It is one of the most important causes of mortality and morbidity worldwide. Particularly in older age groups in the United States, it is among the 10 most important disease causing hospitalizations and death with increasing prevalence day by day (14). Exacerbations are most frequent cause of morbidity, hospital admission and mortality in COPD (15). The exacerbation of the COPD is defined as an acute event characterized by worsening of the respiratory symptoms that was beyond normal day-to-day variations and led to a change in medication (5) . Respiratory failure can be seen in exacerbation of COPD. The arterial blood gas analysis is an important tool for defining respiratory failure and to start NIMV therapy in COPD patients. The relation between RDW and arterial blood gas analysis parameters of COPD patients are also investigated. It is reported that oxygen saturation is significantly lower for patients with an elevated RDW (1).
In our study, it was also found that mean Pa O2 and oxygen saturation values were lower in patients with increased RDW levels compared to normal ones. But, the difference was not In our study, it was not possible to compare the RDW levels according to stages of disease due to its retrospective design. There was a lack of data about health status assessed by modified Medical Research Council (mMRC) Questionnaire or COPD assessment test (CAT) due to retrospective nature of this study. Furthermore, most of the patients were not able to perform the pulmonary function test since they had a severe dyspnea due to exacerbation.
The association between RDW level and length of stay (LOS) in hospital is also investigated in recent studies (11, 16) . RDW is associated with length of stay in hospital and use of vasopressors in hospitalized patients with CAP (11). Greater initial RDW and change of RDW during heart failure hospitalization are associated with longer LOS, suggesting both initial RDW and change of RDW during hospitalization may be helpful in personalizing prognosis and treatment (16) . In contrast, there was no significant difference of LOS in hospital between the groups in our study. It is thought that study populations including different diseases might be responsible for opposite results.
The baseline RDW and increase in RDW during hospitalization are also compared in patients with sepsis and heart failure (16, 17) . It is reported that there is an increase in RDW from baseline during the first 72 hours after hospitalization and it is significantly associated with adverse clinical outcomes in sepsis. Therefore, it is suggested that a combination of baseline RDW value and an increase in RDW can be a promising independent prognostic marker in patients with severe sepsis or septic shock (17) . It is also suggested that both initial RDW and change of RDW during hospitalization may be helpful in personalizing prognosis and treatment in patients with heart failure (16). However, it was not possible to evaluate the role of RDW changes during the hospitalization on adverse clinical outcomes due to retrospective design of this study.
A potential independent association is recently demonstrated between high RDW levels and the risk of all-cause mortality in critically ill patients, although the underlying mechanism is still unclear (17) . Elevated RDW has been associated with adverse outcomes of heart failure, infective endocarditis, VTE, and idiopathic pulmonary hypertension (9,18).
RDW is recognized as a mortality marker in patients with CVD (3). It is also reported that baseline RDW is significantly associated with incidence of fatal cardiac events (19). An increased RDW conveys important information for both short and long term prognosis (3).
Greater initial RDW and change of RDW during heart failure hospitalization are associated with 30-day mortality (16) . RDW is found to be associated with 30-day mortality in hospitalized patients with CAP (11). Even more importantly, the value of RDW is now being regarded as a strong and independent risk factor for death in the general population (2).
Furthermore, studies evaluating the role of RDW on mortality in COPD patients are also support these findings (1, 3) . Elevated RDW levels are associated with increased mortality risk in stable COPD patients (3). It is suggested that there is a correlation between survival of COPD patients and RDW levels (1) . Also, the presence of exitus was significantly higher in patients with increased RDW level in our study as similar to literature.
There were several limitations of this study that should be considered. First, it was a retrospective investigation, and data collection was based on medical records. Second, it reflected the RDW levels of only hospitalized patients with COPD exacerbation. So the study group did not include outpatients and study population was relatively small. The number of exacerbation , n 1 20 2.9 ± 3.4
The number of hospitalization, n 1 12 2.1 ± 2. 
